CCL20



CCL20

A1AA1S2SS2N3NN3Y4YY4D5DD5C6CC6C7CC7L8LL8S9SS9Y10YY10I11II11Q12QQ12T13TT13P14PP14L15LL15P16PP16S17SS17R18RR18A19AA19I20II20V21VV21G22GG22F23FF23T24TT24R25RR25Q26QQ26M27MM27A28AA28D29DD29E30EE30A31AA31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40T41TT41K42KK42K43KK43R44RR44K45KK45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

SMILES None
InChIKey None
Sequence ASNYDCCLSYIQTPLPSRAIVGFTRQMADEACDINAIIFHTKKRKSVCADPKQNWVKRAVNLLSLRVKKM

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL20

A1AA1S2SS2N3NN3Y4YY4D5DD5C6CC6C7CC7L8LL8S9SS9Y10YY10I11II11Q12QQ12T13TT13P14PP14L15LL15P16PP16S17SS17R18RR18A19AA19I20II20V21VV21G22GG22F23FF23T24TT24R25RR25Q26QQ26M27MM27A28AA28D29DD29E30EE30A31AA31C32CC32D33DD33I34II34N35NN35A36AA36I37II37I38II38F39FF39H40HH40T41TT41K42KK42K43KK43R44RR44K45KK45S46SS46V47VV47... and 23 more residue(s)...... and 23 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.